Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics for Traumatic Hemopneumothorax Management
NCT01127880Phase 3Completed
- Sponsor
- St. Luke's Hospital
- Start
- Jul 2005
- Primary completion
- Dec 2009
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cefazolin and clindamycin in empyema and pneumonia, sponsored by St. Luke's Hospital. Primary endpoint: Incidence of empyema at 30 days. Started Jul 2005; status: completed.
02
Drugs
cefazolinclindamycin
03
Conditions
empyemapneumonia
Beyond the preview
Go deeper on NCT01127880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127880.